167 related articles for article (PubMed ID: 38041107)
21. MiR-217 is down-regulated in psoriasis and promotes keratinocyte differentiation via targeting GRHL2.
Zhu H; Hou L; Liu J; Li Z
Biochem Biophys Res Commun; 2016 Feb; 471(1):169-76. PubMed ID: 26826389
[TBL] [Abstract][Full Text] [Related]
22. Regulatory role for Krüppel-like zinc-finger protein Gli-similar 1 (Glis1) in PMA-treated and psoriatic epidermis.
Nakanishi G; Kim YS; Nakajima T; Jetten AM
J Invest Dermatol; 2006 Jan; 126(1):49-60. PubMed ID: 16417217
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of vascular endothelial growth factor (VEGF) receptors on keratinocytes in psoriasis: regulated by calcium independent of VEGF.
Man XY; Yang XH; Cai SQ; Bu ZY; Zheng M
J Cell Mol Med; 2008 Apr; 12(2):649-60. PubMed ID: 18419602
[TBL] [Abstract][Full Text] [Related]
24.
Zhang H; Ren C; Liu Q; Wang Q; Wang D
Allergol Immunopathol (Madr); 2023; 51(3):124-134. PubMed ID: 37169570
[TBL] [Abstract][Full Text] [Related]
25. Podoplanin expression in wound and hyperproliferative psoriatic epidermis: regulation by TGF-β and STAT-3 activating cytokines, IFN-γ, IL-6, and IL-22.
Honma M; Minami-Hori M; Takahashi H; Iizuka H
J Dermatol Sci; 2012 Feb; 65(2):134-40. PubMed ID: 22189341
[TBL] [Abstract][Full Text] [Related]
26. The anti-apoptotic protein G1P3 is overexpressed in psoriasis and regulated by the non-coding RNA, PRINS.
Szegedi K; Sonkoly E; Nagy N; Németh IB; Bata-Csörgo Z; Kemény L; Dobozy A; Széll M
Exp Dermatol; 2010 Mar; 19(3):269-78. PubMed ID: 20377629
[TBL] [Abstract][Full Text] [Related]
27. Induction of normal and psoriatic phenotypes in submerged keratinocyte cultures.
Van Ruissen F; de Jongh GJ; Zeeuwen PL; Van Erp PE; Madsen P; Schalkwijk J
J Cell Physiol; 1996 Aug; 168(2):442-52. PubMed ID: 8707880
[TBL] [Abstract][Full Text] [Related]
28. miR-4516, a microRNA downregulated in psoriasis inhibits keratinocyte motility by targeting fibronectin/integrin α9 signaling.
Chowdhari S; Sardana K; Saini N
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3142-3152. PubMed ID: 28844950
[TBL] [Abstract][Full Text] [Related]
29. Inverse regulation of the nuclear factor-kappaB binding to the p53 and interleukin-8 kappaB response elements in lesional psoriatic skin.
Johansen C; Flindt E; Kragballe K; Henningsen J; Westergaard M; Kristiansen K; Iversen L
J Invest Dermatol; 2005 Jun; 124(6):1284-92. PubMed ID: 15955105
[TBL] [Abstract][Full Text] [Related]
30. The Mad1 transcription factor is a novel target of activin and TGF-beta action in keratinocytes: possible role of Mad1 in wound repair and psoriasis.
Werner S; Beer HD; Mauch C; Lüscher B; Werner S
Oncogene; 2001 Nov; 20(51):7494-504. PubMed ID: 11709721
[TBL] [Abstract][Full Text] [Related]
31. LC-MS/MS analysis of lesional and normally looking psoriatic skin reveals significant changes in protein metabolism and RNA processing.
Sobolev VV; Mezentsev AV; Ziganshin RH; Soboleva AG; Denieva M; Korsunskaya IM; Svitich OA
PLoS One; 2021; 16(5):e0240956. PubMed ID: 34038424
[TBL] [Abstract][Full Text] [Related]
32. Protein expression of TNF-alpha in psoriatic skin is regulated at a posttranscriptional level by MAPK-activated protein kinase 2.
Johansen C; Funding AT; Otkjaer K; Kragballe K; Jensen UB; Madsen M; Binderup L; Skak-Nielsen T; Fjording MS; Iversen L
J Immunol; 2006 Feb; 176(3):1431-8. PubMed ID: 16424170
[TBL] [Abstract][Full Text] [Related]
33. Psoriasis-Associated Inflammatory Conditions Induce IL-23 mRNA Expression in Normal Human Epidermal Keratinocytes.
Kelemen E; Ádám É; Sági SM; Göblös A; Kemény L; Bata-Csörgő Z; Széll M; Danis J
Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008970
[TBL] [Abstract][Full Text] [Related]
34. IL-4 Downregulates IL-1β and IL-6 and Induces GATA3 in Psoriatic Epidermal Cells: Route of Action of a Th2 Cytokine.
Onderdijk AJ; Baerveldt EM; Kurek D; Kant M; Florencia EF; Debets R; Prens EP
J Immunol; 2015 Aug; 195(4):1744-52. PubMed ID: 26170379
[TBL] [Abstract][Full Text] [Related]
35. Activator protein 1 DNA binding activity is decreased in lesional psoriatic skin compared with nonlesional psoriatic skin.
Johansen C; Kragballe K; Rasmussen M; Dam TN; Iversen L
Br J Dermatol; 2004 Sep; 151(3):600-7. PubMed ID: 15377346
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of keratinocyte apoptosis by IL-15: a new parameter in the pathogenesis of psoriasis?
Rückert R; Asadullah K; Seifert M; Budagian VM; Arnold R; Trombotto C; Paus R; Bulfone-Paus S
J Immunol; 2000 Aug; 165(4):2240-50. PubMed ID: 10925312
[TBL] [Abstract][Full Text] [Related]
37. Elevated serum levels of calcium-binding S100 proteins A8 and A9 reflect disease activity and abnormal differentiation of keratinocytes in psoriasis.
Benoit S; Toksoy A; Ahlmann M; Schmidt M; Sunderkötter C; Foell D; Pasparakis M; Roth J; Goebeler M
Br J Dermatol; 2006 Jul; 155(1):62-6. PubMed ID: 16792753
[TBL] [Abstract][Full Text] [Related]
38. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
[TBL] [Abstract][Full Text] [Related]
39. Negative regulation of two hyperproliferative keratinocyte differentiation markers by a retinoic acid receptor-specific retinoid: insight into the mechanism of retinoid action in psoriasis.
Nagpal S; Thacher SM; Patel S; Friant S; Malhotra M; Shafer J; Krasinski G; Asano AT; Teng M; Duvic M; Chandraratna RA
Cell Growth Differ; 1996 Dec; 7(12):1783-91. PubMed ID: 8959347
[TBL] [Abstract][Full Text] [Related]
40. RNA, DNA, and cell surface characteristics of lesional and nonlesional psoriatic skin.
Staiano-Coico L; Gottlieb AB; Barazani L; Carter DM
J Invest Dermatol; 1987 May; 88(5):646-51. PubMed ID: 2437219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]